Latest Investment Opportunities News

Page 12 of 16
Washington H. Soul Pattinson reports a solid FY25 with rising net asset value and a 27th consecutive dividend increase, outperforming market benchmarks despite volatility.
Victor Sage
Victor Sage
1 Aug 2025
Omni Bridgeway Limited has reported record investment proceeds of A$555.5 million for FY25, underpinned by robust completions and a growing pipeline. Positive regulatory shifts in key markets further bolster the company’s outlook.
Claire Turing
Claire Turing
31 July 2025
Assetora Limited has strengthened its financial footing with over two quarters of funding and secured a pivotal role as Responsible Entity of the DomaCom Fund, alongside a strategic $700 million mortgage management agreement.
Claire Turing
Claire Turing
30 July 2025
Prescient Therapeutics has raised $6.8 million through a Share Purchase Plan to fund the Phase 2 development of its novel cancer therapy PTX-100, while launching a discounted placement to sophisticated investors.
Ada Torres
Ada Torres
29 July 2025
Clime Investment Management has reported a solid operating profit for the June quarter, declared a fully franked dividend, and announced strategic expansions in staff and product offerings.
Claire Turing
Claire Turing
29 July 2025
Beacon Minerals has announced a $12 million on-market share buy-back program aiming to enhance shareholder value and capital efficiency, with purchases starting August 1, 2025.
Maxwell Dee
Maxwell Dee
21 July 2025
Equity Story Group has secured a transformative acquisition of Baker Young Limited, marking its entry into full-service wealth management and a major boost to its national footprint and recurring revenue.
Claire Turing
Claire Turing
21 July 2025
Arika Resources has responded to an ASX price query, confirming no undisclosed information behind recent share price movements and highlighting its active drilling program and recent $5 million capital raise.
Maxwell Dee
Maxwell Dee
18 July 2025
Hydrocarbon Dynamics Limited has announced a 1 for 3 entitlement offer to raise up to $718,000, aiming to fund marketing of its HCD Multi-Flow® product and explore new energy technology investments.
Maxwell Dee
Maxwell Dee
17 July 2025
Prescient Therapeutics has extended its Share Purchase Plan closing date to 22 July 2025, aiming to raise up to A$7 million to advance its targeted cancer therapy PTX-100 through Phase 2 clinical trials.
Ada Torres
Ada Torres
15 July 2025
FleetPartners Group has successfully priced a A$400 million Australian asset-backed securitisation, including a green tranche funding electric vehicle leases, while issuing a correction to a previous announcement.
Claire Turing
Claire Turing
9 July 2025
FleetPartners has priced a A$400 million asset backed securitisation, featuring a green tranche dedicated to electric vehicle leases, marking a notable step in sustainable finance.
Claire Turing
Claire Turing
8 July 2025

Browse the archive

Full archive